Related Experiment Video
Updated: Aug 18, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
DNA ploidy as a prognostic factor in patients with ovarian carcinoma
1Department of Gynaecological Oncology, M. Skłodowska-Curie Memorial Cancer Center, Warszawa.
Abstract:
The aim of this work was to establish the dependence between survival and time to progression and the factor which is considered as risk factor i.e. type of DNA ploidy. The DNA ploidy was evaluated in 33 cases of ovary carcinoma selected from 314 cases. The statistically significant difference between the 5 years survivals in patients with DNA aneuploidy and patients with DNA diploidy was observed (13.6% vs 60.9%). What was also found out, was the statistically significant difference between the 5 years survivals without the progression of disease in patients with DNA aneuploidy and patients with DNA diploidy (13.6% vs 55.9%).
More Related Videos
Related Concept Videos
Oogenesis
Nondisjunction

